Pathogenesis
Pathogenesis of intrahepatic cholestasis of pregnancy is unclear
- multiple factors probably interact with a genetic predisposition to alter the membrane composition of bile ducts and hepatocytes and increase their sensitivity to sex steroids
- a family history (autosomal dominant and possibly X linked) is commonly associated with haplotypes HLA-B8 and HLA-Bw16
- hormonal factors are implicated because intrahepatic cholestasis worsens with multiple pregnancies and can recur with menstruation and oestrogen treatment
- occurs more commonly in mothers of patients with rare, inborn cholestatic syndromes such as progressive familial intrahepatic cholestasis type 3 or recurrent familial intrahepatic cholestasis, both related to dysfunction of biliary transporters
Reference:
- Walker KF et al. Pharmacological interventions for treating intrahepatic cholestasis of pregnancy. Cochrane Database of Systematic Reviews 2020, Issue 7. Art. No.: CD000493. DOI: 10.1002/14651858.CD000493.pub3.
- Royal College of Obstetricians and Gynaecologists. Intrahepatic cholestasis of pregnancy (Green-top Guideline No. 43). Published August 2022
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.